| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |